These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28196623)

  • 1. Health Care Utilization and Direct Costs in Mild, Moderate, and Severe Adult Asthma: A Descriptive Study Using the 2014 South Korean Health Insurance Database.
    Lee YJ; Kwon SH; Hong SH; Nam JH; Song HJ; Lee JS; Lee EK; Shin JY
    Clin Ther; 2017 Mar; 39(3):527-536. PubMed ID: 28196623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA.
    Suruki RY; Daugherty JB; Boudiaf N; Albers FC
    BMC Pulm Med; 2017 Apr; 17(1):74. PubMed ID: 28449686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of asthma exacerbation based on asthma severity: a nationwide population-based observational study in South Korea.
    Kang HR; Song HJ; Nam JH; Hong SH; Yang SY; Ju S; Lee SW; Kim TB; Kim HL; Lee EK
    BMJ Open; 2018 Mar; 8(3):e020825. PubMed ID: 29567854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cost-of-illness study of asthma in Korea: estimated from the Korea National Health insurance claims database].
    Park CS; Kang HY; Kwon I; Kang DR; Jung HY
    J Prev Med Public Health; 2006 Sep; 39(5):397-403. PubMed ID: 17076180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS; Yawn BP
    Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pregnancy in asthma on health care use and perinatal outcomes.
    Kim S; Kim J; Park SY; Um HY; Kim K; Kim Y; Park Y; Baek S; Yoon SY; Kwon HS; Cho YS; Moon HB; Kim TB
    J Allergy Clin Immunol; 2015 Nov; 136(5):1215-23.e1-6. PubMed ID: 26071938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cost and management of asthma exacerbations in Spanish hospitals (COAX study in hospital services)].
    Borderías Clau L; Zabaleta Murguionda M; Riesco Miranda JA; Pellicer Ciscar C; Hernández Hernández JR; Carrillo Díaz T; Lumbreras García G
    Arch Bronconeumol; 2005 Jun; 41(6):313-21. PubMed ID: 15989888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic analysis of the phase III MENSA study evaluating mepolizumab for severe asthma with eosinophilic phenotype.
    Basu A; Dalal A; Canonica GW; Forshag M; Yancey SW; Nagar S; Bell CF
    Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):121-131. PubMed ID: 28277854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate symptom-based exacerbations as predictors of severe claims-based exacerbations in asthma.
    Lane SJ; Petersen H; Seltzer JM; Blanchette CM; Navaratnam P; Allen-Ramey F; Fuhlbrigge A
    J Asthma; 2013 Aug; 50(6):642-8. PubMed ID: 23514102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma.
    Johansson G; Andreasson EB; Larsson PE; Vogelmeier CF
    Pharmacoeconomics; 2006; 24(7):695-708. PubMed ID: 16802845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma.
    Ivanova JI; Bergman R; Birnbaum HG; Colice GL; Silverman RA; McLaurin K
    J Allergy Clin Immunol; 2012 May; 129(5):1229-35. PubMed ID: 22326484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic burden of asthma in Korea.
    Lee YH; Yoon SJ; Kim EJ; Kim YA; Seo HY; Oh IH
    Allergy Asthma Proc; 2011; 32(6):35-40. PubMed ID: 22221428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a New Risk Measure for Chronic Obstructive Pulmonary Disease Exacerbation Using Health Insurance Claims Data.
    Stanford RH; Nag A; Mapel DW; Lee TA; Rosiello R; Vekeman F; Gauthier-Loiselle M; Duh MS; Merrigan JF; Schatz M
    Ann Am Thorac Soc; 2016 Jul; 13(7):1067-75. PubMed ID: 27070274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare costs and resource utilization of asthma in Germany: a claims data analysis.
    Jacob C; Bechtel B; Engel S; Kardos P; Linder R; Braun S; Greiner W
    Eur J Health Econ; 2016 Mar; 17(2):195-201. PubMed ID: 25716136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic impact of severe asthma exacerbations in Spain: multicentre observational study.
    Quirce S; Melero C; Huerta A; Uría E; Cuesta M
    J Asthma; 2021 Feb; 58(2):207-212. PubMed ID: 31621441
    [No Abstract]   [Full Text] [Related]  

  • 16. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic costs for adult asthmatics according to severity and control status in Korean tertiary hospitals.
    Kim SH; Kim TW; Kwon JW; Kang HR; Lee YW; Kim TB; Kim SH; Park HW; Park SW; Chang YS; Cho YS; Park JW; Cho YJ; Yoon HJ; Cho SH; Choi BW; Moon HB; Min KU
    J Asthma; 2012 Apr; 49(3):303-9. PubMed ID: 22185405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using medication utilization information to develop an asthma severity classification model.
    Yu TH; Fu PK; Tung YC
    BMC Med Inform Decis Mak; 2017 Dec; 17(1):177. PubMed ID: 29262809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic impact of severe asthma in Spain: multicentre observational longitudinal study.
    Melero Moreno C; Quirce S; Huerta A; Uría E; Cuesta M
    J Asthma; 2019 Aug; 56(8):861-871. PubMed ID: 30003827
    [No Abstract]   [Full Text] [Related]  

  • 20. Health-care utilization and costs with fluticasone propionate and fluticasone propionate/salmeterol in asthma patients at risk for exacerbations.
    Hagiwara M; Delea TE; Stanford RH
    Allergy Asthma Proc; 2014; 35(1):54-62. PubMed ID: 24433597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.